Pharmafile Logo
Pharmafocus logo
Advanced Search

GlaxoSmithKline

Showing 15 posts of 164 posts found.

GSK’s gene therapy for rare condition in children gets EMA backing

April 4, 2016
Research and Development, Sales and Marketing ADA-SCID, European Medicines Agency, GlaxoSmithKline, Orphan Therapy, Rare Treatment, drug trial, gene therapy

UK drug major GlaxoSmithKline (LSE: GSK) has won marketing recommendation from European regulators for its first gene therapy to treat …

News
gsk_corp_hq_brentford_2

GSK’s Nucala gets regulatory approval in Japan to treat bronchial asthma

March 29, 2016
Manufacturing and Production, Research and Development GlaxoSmithKline, Japan, Nucala, US FDA, bronchial asthma

GlaxoSmithKline (LSE: GSK) on Tuesday said the Japanese regulators have approved its drug to treat bronchial asthma.  The Japanese Ministry …

News

Sir Andrew Witty announces decision to step down as CEO of GSK

March 17, 2016
Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down

Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …

News
gsk_l_rgb-web

GSK establish cell and gene therapy collaboration with Miltenyi Biotec

March 16, 2016
Medical Communications, Research and Development GSK, GlaxoSmithKline, cell and gene therapy, collaboration, miltenyi biotec

GlaxoSmithKline (NYSE:GSK) has announced a strategic collaboration with Miltenyi Biotec that will see GSK’s expertise in developing cell and gene …

News
gsk_corp_hq_brentford_2

GSK says long-term study for Nucala backs safety profile

March 8, 2016
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, Nucala, asthma

UK pharma major GlaxoSmithKline (LSE: GSK) said its asthma drug, Nucala (mepolizumab) showed a similar safety profile in a long-term …

News
drugs_generic

Delivering successful new drugs

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, patents, pharma

Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …

Feature
Researcher

Big pharma and UK universities launch £40m innovation fund

January 25, 2016
Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …

News

GSK begins work on £100m India facility

September 9, 2015
Manufacturing and Production GlaxoSmithKline, India, manufacturing

GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …

News
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015
Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …

News
GSK image

GSK investigator freed from Chinese prison

June 10, 2015
Medical Communications, Sales and Marketing China, GSK, GlaxoSmithKline, brett wells, bribery, scandal

British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …

News
Perrigo image

Perrigo buys OTC products from GSK

June 3, 2015
Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells

In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …

News

Analysts predict Pfizer to swallow GSK

May 21, 2015
Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger

GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …

News
GSK image

GSK shingles vaccine performs

April 29, 2015
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, HZ/su, Merck, zostovax

GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage …

News
Astrazeneca image

AstraZeneca bags another FDA orphan status in cancer

April 17, 2015
Sales and Marketing AstraZeneca, Cancer, FDA, GlaxoSmithKline, mekinist, melanoma, oncology, selumetinib, trametinib

The FDA has granted AstraZeneca’s cancer medicine selumetinib orphan drug designation for the treatment of uveal melanoma. The company will …

News
abpi_and_nihr_conference_nov13

Funding boost for UK drugs manufacturing

March 30, 2015
Manufacturing and Production, Sales and Marketing ABPI, AstraZeneca, BIA, Bristol-Myers Squibb, Britest, Cambridge, Cambridge Crystallographic Data Centre, GlaxoSmithKline, Perceptive Engineering, Pfizer, Process Systems Enterprise, UCB, University of Leeds, amsci, mmip, stfc

The UK government is funding new manufacturing partnerships that will improve design processes and supply chain initiatives to lift the …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026